{
  "docId": "019de072-1e7f-7432-8113-f418b135b18e",
  "docSlug": "8181c9d0b78b17baf42d7284d4ec3f86",
  "documentTitle": "BioNTech | Investor Day Presentation Deck | 15 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 15,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-1e7f-7432-8113-f418b135b18e/3",
  "deckHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e",
  "deckJsonHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e.json",
  "deckAnchorHref": "/decks/019de072-1e7f-7432-8113-f418b135b18e#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.1,
        "x": 0.86,
        "y": 0.05
      },
      "kind": "image",
      "text": "BIONTECH",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93522d1b-6556-4684-8d2e-3b3b3debf8c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.28
      },
      "kind": "list",
      "text": "BioNTech's Marburg site is one of the largest mRNA vaccine manufacturing sites",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0dcd8f6e-68b7-483b-ba50-853075cf23af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.65
      },
      "kind": "list",
      "text": "50% boost in staff planned in 2022 (+ 250 jobs)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ef96724-821c-42c6-98d1-59dd8bfd6429",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.7,
        "x": 0.15,
        "y": 0.45
      },
      "kind": "list",
      "text": "Supply of mRNA for more than 1.2 bn doses of the COVID-19 vaccine in 2021 as part of a European manufacturing network",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9be6da75-6651-4722-862c-1b5bd4ec484a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.82
      },
      "kind": "list",
      "text": "~ EUR 50 million to be invested in Marburg site in 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e28e463c-70f3-42a4-a055-f0f257dab3ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "Marburg is our largest manufacturing site",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "972d5448-6d61-45f2-8c3e-a0ce7faeab29",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 1,
      "beatId": "281898e6-42c8-44c0-9eca-9ad9c8499a1c",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 1-4 introduce the context and the need for a scalable manufacturing solution in Africa",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "61ea83e6-0551-414f-8415-15206779cbdd",
      "evidence": "The presentation implies that the cost of inaction is limited access to life-saving vaccines",
      "position": 0,
      "objective": "What is the cost of not facilitating access to mRNA vaccines in Africa?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}